AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest™: FDA-Approved Biosimilars Outpaces Cell and Gene Therapy Amid Complex Regulatory Challenges
October 22, 2024 10:00 ET
|
AscellaHealth, LLC
BERWYN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today released its latest...
AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
October 17, 2024 06:00 ET
|
AscellaHealth, LLC; CHAPPER healthcare
AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients
September 04, 2024 08:00 ET
|
World Orphan Drug Alliance (WODA); Oncopeptides AB, Veld Pharmaceuticals GmbH, Slavpharma GmbH
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients
World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent
April 08, 2024 07:30 ET
|
World Orphan Drug Alliance (WODA)
World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent
The North America Rare Disease Summit focused on the need for centralized data to improve the lives of 30 million people living with rare conditions
November 02, 2023 15:51 ET
|
Bamberg Health
Stakeholders debate at the North America Rare Disease Summit on the challenges regarding treatment approvals and the importance of a proactive registry
Orphan Drugs market is projected to grow at a CAGR of 11.1% by 2033: Visiongain
October 05, 2023 10:21 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Orphan Drugs Market Report 2023-2033: Forecasts by Therapeutic Area (Cancer, Neurological Diseases, Cardiovascular Diseases, Hematologic Disorders,...
[Newly launched] Orphan Drugs Market is estimated to be US$ 869.6 billion by 2030 with a CAGR of 10.4% during the forecast period – By PMI
September 12, 2023 13:30 ET
|
PMI
Covina , Sept. 12, 2023 (GLOBE NEWSWIRE) -- Introduction: Orphan drugs are used to treat and diagnose an orphan disease which can be serious or even cause life-threating. Orphan drugs are not...
Orphan Drugs Market to Experience Substantial Growth of 359.86 Billion by 2030, Size, Share, Trends, Demand, Opportunities, Growth Rate and Competitive Landscape
April 27, 2023 17:30 ET
|
Data Bridge Market Research
Vancouver, April 27, 2023 (GLOBE NEWSWIRE) -- In its latest report, Data Bridge Market Research dissects growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and...
World Orphan Drug Alliance Expands to China, Israel, and Greece, Cyprus, and Malta
March 14, 2023 08:00 ET
|
World Orphan Drug Alliance (WODA)
Greater China region, Israel, and Greece, Cyprus and Malta are now also covered by the alliance. With the addition of three new WODA members - RareStone Group, CTS, and Path Pharma - WODA now provides...
Global Orphan Drugs Market Size – Forecasts to 2028
January 09, 2023 09:00 ET
|
Global Market Estimates
Brooklyn, New York, Jan. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global orphan drugs market is expected to grow from USD...